Brief: India's Strides Pharma Science Reports Sept-Quarter Consol Net Profit
14/11/2022 09:59
Nov 14 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* INDIA'S STRIDES PHARMA SCIENCE LTD SEPT-QUARTER CONSOL NET PROFIT 228.3
MILLION
RUPEES VERSUS LOSS 1.63 BILLION RUPEES
* STRIDES PHARMA SCIENCE LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS
8.97
BILLION RUPEES VERSUS 7.21 BILLION RUPEES
Source text for Eikon: ID:nBSEflLf3
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees